Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 27, 2024--
The "Induced Pluripotent Stem Cells Market" report has been added to ResearchAndMarkets.com's offering.
The Induced Pluripotent Stem Cells Market was valued at USD 3.4 billion in 2023, and is projected to reach USD 5.2 billion by 2028, rising at a CAGR of 9.10%.
The rapid evolution of human iPSC technology since 2007 led to an exciting new age for the fields of disease modeling, drug discovery, stem cell biology and regenerative medicine. However, there are certain challenges associated with the use of iPSCs, including issues with clonal selection, in vitro culture, adaptability, and/or cell multiplication. Thus, even though the field of iPSCs has come a long way, there are still many issues that need to be seriously addressed to transform hope to reality regarding the effective clinical application of these cells in regenerative medicine.
Report Scope
This report summarizes the single-use technologies market, including a market snapshot and company profiles of key players. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical market players' financials, product portfolios and recent activities.
The report analyzes and makes projections for each market and its applications, along with forecasts for the next five years. The report also features profiles of leading companies in the biopharmaceutical single-use technologies industry, including Sartorius AG, Danaher Corp, Merck KGaA and Thermo Fisher Scientific Inc.
Data for market estimates have been provided for 2021 and 2022 as the historical years, 2023 as the base year and forecast through 2029.
The report includes:
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 152 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $3.4 Billion |
| Forecasted Market Value (USD) by 2028 | $5.2 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
Chapter 2 Market Overview
Chapter 3 Market Dynamics
Chapter 4 Emerging Technologies and Developments
Chapter 5 Clinical Trial Analysis
Chapter 6 Patent Analysis
Chapter 7 Market Segmentation Analysis
Chapter 8 Competitive Intelligence
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/e5l2jx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241127314973/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH STEM CELLS
SOURCE: Research and Markets
Copyright Business Wire 2024.
PUB: 11/27/2024 09:25 AM/DISC: 11/27/2024 09:24 AM
http://www.businesswire.com/news/home/20241127314973/en